CSL Seqirus Products

This is a complete list of all products marketed by CSL Seqirus worldwide. Not all products are available in every country.

Visit the Global Selector to link to a specific country.

Afluria® Quadrivalent | Inactivated Quadrivalent Influenza Vaccine (split viron)
Also marketed as Afluria® Quad and Afluria® Tetra in various different markets.

Afluria® | Inactivated Influenza Vaccine (split viron)
Also marketed as Enzira®, Fluvax® and Nilgrip® in various different markets.

Agrippal® | Influenza Vaccine (surface antigen inactivated)
Also marketed as Begripal®, Fluazur®, Agriflu®, Chiroflu® in various different markets.

Fluad® | Inactivated Influenza Vaccine, Adjuvanted
Also marketed as Chiromas® in Spain.

Fluad® Pediatric | Inactivated Influenza Vaccine, Adjuvanted

Fluad® Quadrivalent | Inactivated Quadrivalent Influenza Vaccine, Adjuvanted
Also marketed as Fluad® Quad and Fluad® Tetra▼ in various different markets.

Flucelvax® Quadrivalent | Inactivated Influenza Vaccine
Also marketed as Flucelvax® TETRA▼ or Flucelvax® QUAD in various different markets

The trademarks marked ® are registered by Seqirus UK Limited or its affiliates in one or more jurisdictions, unless indicated otherwise.

Areas of Expertise

Influenza Vaccines

We are one of the world’s largest influenza vaccine companies with a singular global focus on influenza.

Learn More About Our Vaccines

Pandemic Response

Experts agree that there will be another influenza pandemic this century¹. CSL Seqirus offers a portfolio of pandemic vaccines and services for rapid response.

Learn More About Our Pandemic Response

In-Licensing

CSL Seqirus is the largest fully integrated commercialisation partner for vaccines and pharmaceuticals in Australia and New Zealand.

Learn More About Our In-Licensing Programs

Antivenoms and Q fever vaccine

CSL Seqirus is the supplier of a unique range of antivenoms and Q fever vaccine for the Australian government.

Learn More About These Programs

GBR-FLU-0006 February 2021